Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
Jiaming Lai, Ling Luo, Ting Zhou, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1356-1356
Open Access | Times Cited: 22

Showing 22 citing articles:

Gut microbiota: the pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease
Giuseppe Guido Maria Scarlata, Ludovico Abenavoli
Expert Review of Gastroenterology & Hepatology (2025), pp. 1-4
Closed Access | Times Cited: 2
Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease
Carmen Colaci, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
Hepatoma Research (2024) Vol. 10, pp. 16-16
Open Access | Times Cited: 13
From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
Mi Zhou, Jianyu Lv, Han Y. H. Chen, et al.
Annals of Hepatology (2025), pp. 101777-101777
Open Access | Times Cited: 1
Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases
Yanyan Wang, Huangru Xu, Xiqiao Zhou, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 262-283
Open Access | Times Cited: 8
Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease
Jakub Rochoń, Piotr Kalinowski, Ksenia Szymanek-Majchrzak, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 23, pp. 2964-2980
Open Access | Times Cited: 8
Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
Hao Chen, Yang Zhou, Haiping Hao, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 8, pp. 724-745
Closed Access | Times Cited: 5
Genetically predicted blood metabolites mediate the association between immune cell characteristics and urolithiasis: A Mendelian randomization study and mediation analysis
Chengcheng Wei, Juan He, Jun Wen, et al.
Genes & Diseases (2025), pp. 101547-101547
Open Access
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
Christopher D. Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
Determining Urinary Bile Acid Profiles to Predict Maternal and Neonatal Outcomes in Patients with Intrahepatic Cholestasis of Pregnancy
平野 恭悠, Min Ding, Xue Li, et al.
Diagnostics (2025) Vol. 15, Iss. 6, pp. 657-657
Open Access
The Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease
Diren Beyoğlu, Jeffrey R. Idle
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2882-2882
Open Access
Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver disease
Sa Lyu, Jiani Yang, Xin Xin, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases
Josh Bilson, Eleonora Scorletti, Jonathan R. Swann, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 841-841
Open Access | Times Cited: 3
Metabolomics analysis of patients with Schistosoma japonicum infection based on UPLC-MS method
Junhui Li, Jie Jiang, Yi Zhu, et al.
Parasites & Vectors (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
The bile acid profile
Zhenhua Liu, Chongge You
Clinica Chimica Acta (2024) Vol. 565, pp. 120004-120004
Closed Access | Times Cited: 3
Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration
Aleksandra Bołdys, Łukasz Bułdak
World Journal of Gastroenterology (2024) Vol. 30, Iss. 18, pp. 2387-2390
Open Access | Times Cited: 2
Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD)
Irene Mignini, Linda Galasso, Giulia Piccirilli, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1532-1532
Open Access | Times Cited: 1
An Atlas of Inter-Organ Metabolite Trafficking in Health and Atherogenic Conditions
Hosung Bae, Sunhee Jung, Johnny Le, et al.
(2024)
Closed Access | Times Cited: 1
Exploring serum bile acids as potential noninvasive biomarkers for nonalcoholic fatty liver disease
Ashraf A. Basuni, Dina Sweed, Mohammed Fathey Elgazzar, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access
Lactobacillus sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice
Titilayo Olotu, Jessica M. Ferrell
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2488-2488
Open Access
Molecular Pathways Linking High-Fat Diet and PM2.5 Exposure to Metabolically Abnormal Obesity: A Systematic Review and Meta-Analysis
Sagrario Lobato, Víctor Manuel Salomón-Soto, Claudia Méndez, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1607-1607
Open Access
Insights of Direct and Indirect Regulation of PXR through Phosphorylation in Fatty Liver Disease
Veronia Basaly, Anisha Bhattacharya, Grace L. Guo
Molecular Pharmacology (2024) Vol. 107, Iss. 2, pp. 100014-100014
Closed Access
The clinician's view on the advantages and contradictions of the new nomenclature of steatotic liver disease: A review
Chavdar S Pavlov, Daria Teplyuk, Л. Б. Лазебник, et al.
Terapevticheskii arkhiv (2024) Vol. 96, Iss. 4, pp. 429-435
Open Access
Genetically predicted metabolites mediate the association between immune cells and metabolic dysfunction-associated steatotic liver disease: a mendelian randomization study
Dan Ye, Jiaofeng Wang, Jiaheng Shi, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access
Page 1

Scroll to top